Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics.

Journal Information

Full Title: Pharmaceuticals (Basel)

Abbreviation: Pharmaceuticals (Basel)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"to identify ?-synuclein binders a virtual hts was performed using swisssimilarity ( table 2 ) a web-accessible tool for identifying putative hits using a diverse collection of promising and validated small molecule libraries including but not limited to 3071 approved drugs and 2989 drug candidates from the chembl 29 database over 320000 commercially available molecules from the specs library over 9 million molecules from the zinc20 database and over 30 million molecules from the enamine "real" catalog [ ]."

Code Sharing
Evidence found in paper:

"Conflicts of Interest Jermaine Ross is an employee of Alleo Labs and has received a research grant from the Alzheimer’s Disease Data Initiative as a William H. Gates Sr. fellow (no grant number). Yoonjeong Cha is an employee of Alleo Labs. Mohamedi N. Kagalwala is an employee of Alleo Labs."

Evidence found in paper:

"The authors acknowledge financial support from the Alzheimer’s Disease Data Initiative and the NVIDIA Inception Program."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025